OVER-AB Tackling Antibiotic Over-prescription
- Coordinator
- Shanx Medtech B.v., Netherlands
- Runs
- 1 September 2023 to 31 August 2024
- Status
- Finished
- EU funding
- €75k
- Total cost
- —
- Partners
- 1 organisations in 1 countries
- Type
- Coordination and Support Action
- Grant agreement
- 101113944
What the project is doing
In the project's own words, from its summary on CORDIS.
Within the ever changing and ever innovative field of healthcare diagnostics, ShanX Medtech and Dr. Sophia Eriola Shanko are dedicated to bringing personalised diagnostic testing to the point-of-care, ensuring the timely and appropriate administration of antibiotics to patients. Worldwide over 400 million people visit their doctor with a Urinary Tract Infection (UTI) every year. With the majority of UTIs stemming from a bacterial infection, the treatment thereof is straightforward: an antibiotic prescription.
However, for physicians determining the correct antibiotic treatment for each patient remains problematic. Furthermore, the global increase in antibiotic resistance rates reinforces the need to improve antibiotic prescription protocols. ShanX is developing a diagnostic tool that can be used at the doctor's premises and it allows the physician to test a series of antibiotics prior to administration, thereby ensuring the subsequent treatment efficacy.
The results provided are fast, accurate, and tailored to each individual patient. ShanX Medtech is revolutionizing the antibiotic treatment workflow by enabling fast, evidence-based and personalized antibiotic administration. Sophia is proudly building a world where women, like herself, are defining and designing a better future for patient care. She hopes that her positivity and charisma serve as an inspiration to others, and that – while leading by example – true passion paired with determination and grit, can empower women to meet their potential and pursue entrepreneurship.
Topics
Who is involved
| Organisation | City | Country | Role |
|---|---|---|---|
| Shanx Medtech B.v. | Eindhoven | Netherlands | Coordinator |
Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI